Basic Search
|
Summaries
|
Advanced Search
Violation Tracker Current Parent Company Summary
Current Parent Company Name: Sanofi
Ownership Structure: publicly traded
Headquartered in: France
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals
Penalty total since 2000: $641,786,117
Number of records: 28
| Top 5 Offense Groups (Groups Defined) | Penalty Total | Number of Records |
| government-contracting-related offenses | $489,458,415 | 15 |
| competition-related offenses | $79,467,000 | 5 |
| safety-related offenses | $55,788,039 | 3 |
| employment-related offenses | $15,360,000 | 1 |
| consumer-protection-related offenses | $1,600,000 | 1 |
| Top 5 Primary Offense Types | Penalty Total | Number of Records |
| False Claims Act and related | $489,458,415 | 15 |
| drug or medical equipment safety violation | $55,781,039 | 2 |
| price-fixing or anti-competitive practices | $53,650,000 | 3 |
| Foreign Corrupt Practices Act | $25,200,000 | 1 |
| employment discrimination | $15,360,000 | 1 |
Notes: Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the
Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.
Links: Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found
here.
For an overview of assistance this company is receiving under the CARES Act, see its Covid Stimulus Watch summary page
here.
Individual Penalty Records:
Click on the company or penalty amount for more information on each case.
| Company | Primary Offense Type  . | Year | Agency | Penalty Amount |
| Sanofi-Aventis | consumer protection violation | 2019 | WV-AG | $1,600,000 |
| Genzyme Corporation | drug or medical equipment safety violation | 2015 | FDA | $32,587,439 |
| Roussel Uclaf S.A. | drug or medical equipment safety violation | 2001 | USAO | $23,193,600 |
| Sanofi-Aventis U.S. LLC | employment discrimination | 2010 | private lawsuit-federal | $15,360,000 |
| SANOFI PASTEUR | environmental violation | 2006 | PA-ENV | $28,620 |
| SANOFI PASTEUR | environmental violation | 2007 | PA-ENV | $6,400 |
| IMO SANOFI PASTEUR | environmental violation | 2014 | EPA | $77,643 |
| Sanofi-Aventis U.S. Inc. | False Claims Act and related | 2012 | DOJ_CIVIL | $109,000,000 |
| Genzyme Corp. | False Claims Act and related | 2013 | DOJ_CIVIL | $22,280,000 |
| Aventis Pharmaceutical Inc. | False Claims Act and related | 2009 | DOJ_CIVIL | $95,500,000 |
| Aventis Pharmaceuticals Inc. | False Claims Act and related | 2007 | DOJ_CIVIL | $190,000,000 |
| Sanofi-Pasteur | False Claims Act and related | 2017 | DOJ_CIVIL | $19,868,194 |
| Aventis | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
| Aventis Pharmaceutical Inc. | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000 |
| Aventis Pharmaceutical L.P. | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
| Aventis Pharmaceuticals Inc. | False Claims Act and related | 2007 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,645,600 |
| Aventis Pharmaceuticals Inc. | False Claims Act and related | 2010 | NJ-AG | $1,300,000 |
| Aventis Pharmaceuticals, Inc. and Aventis Behring, LLC | False Claims Act and related | 2012 | KY-AG | $2,290,000 |
| Genzyme Corp. | False Claims Act and related | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,280,000 |
| Sanofi-Aventis U.S. LLC | False Claims Act and related | 2012 | ID-AG | $828,500 |
| Aventis Pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $14,708,388 |
| Sanofi-Aventis U.S., LLC | False Claims Act and related | 2020 | USAO | $11,850,000 |
| Sanofi | Foreign Corrupt Practices Act | 2018 | SEC | $25,200,000 |
| Sanofi US Services, Inc. | kickbacks and bribery | 2013 | MULTI-AG | $617,000 |
| Hoechst AG | price-fixing or anti-competitive practices | 2003 | DOJ_ANTITRUST | $12,000,000 |
| Aventis Pharmaceuticals Inc. | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $40,000,000 |
| Aventis Pharmaceuticals, Inc. | price-fixing or anti-competitive practices | 2012 | MULTI-AG | $1,650,000 |
| SANOFI PASTEUR INC. | workplace safety or health violation | 2014 | OSHA | $7,000 |
